Using French health-insurance and medication-safety data, the authors estimated ADHD identification around 0.3% among children ages 6–11. The abstract contrasts that estimate with an earlier 3.5%–5.6% estimate for ages 6–12 and calls for further contradictory studies.
We claim that an adequate estimate of the ADHD prevalence rate in France fluctuates around 0.3% of children aged 6 to 11.
Using French health-insurance and medication-safety data, the authors estimated ADHD identification around 0.3% among children ages 6–11. The abstract contrasts that estimate with an earlier 3.5%–5.6% estimate for ages 6–12 and calls for further contradictory studies. Claims-based identification is not necessarily underlying population prevalence. MMG-38 is a published methodological challenge to the 0.3% estimate.